PTPRC (CD45) variation and disease association studied using single nucleotide polymorphism tagging

Tissue Antigens

Volumn 71, Issue 5, 2008, Pages 458-463

  Hennig, B J ^a   Fry, A E ^a   Hirai, K ^b   Tahara, H ^b   Tamori, A ^b   Moller, M ^c   Hopkin, J ^c   Hill, A V ^a   Bodmer, W ^d   Beverley, P ^e   Tchilian, E ^f  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SWANSEA UNIVERSITY   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e Churchill Hospital   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

A138G; C77G; Case control; Disease association; Graves' disease; PTPRC (CD45); Tuberculin response; Type 1 diabetes

Indexed keywords

CD45 ANTIGEN;

ADOLESCENT; ALLELE; ARTICLE; CHILD; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HEPATITIS C; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MAJOR CLINICAL STUDY; POPULATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULIN TEST; UNITED KINGDOM;

ALLELES; ANTIGENS, CD45; ASCARIASIS; CHINA; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; GREAT BRITAIN; HAPLOTYPES; HEPATITIS C; HUMANS; JAPAN; PARASITE EGG COUNT; POLYMORPHISM, SINGLE NUCLEOTIDE; TUBERCULIN;

HEPATITIS C VIRUS;

EID: 42149136356     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01014.x     Document Type: Article

References (23)

1. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003 : 21 : 107 37.
2. Tchilian EZ, Beverley PC. Altered CD45 expression and disease. Trends Immunol 2006 : 27 : 146 53.
3. Boxall S, Stanton T, Hirai K et al. Disease associations and altered immune function in CD45 138G variant carriers. Hum Mol Genet 2004 : 13 : 2377 84.
4. Ward V, Hennig BJ, Hirai K et al. Geographical distribution and disease associations of the CD45 exon 6 138G variant. Immunogenetics 2006 : 58 : 235 9.
5. Tchilian EZ, Wallace DL, Dawes R et al. A point mutation in CD45 may be associated with HIV-1 infection. AIDS 2001 : 15 : 1892 4.
6. Ballerini C, Rosati E, Salvetti M et al. Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population. Neurosci Lett 2002 : 328 : 325 7.
7. Barcellos LF, Caillier S, Dragone L et al. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients. Nat Genet 2001 : 29 : 23 4.
8. Cocco E, Murru MR, Melis C et al. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients. J Neurol 2004 : 251 : 1085 8.
9. Vogel A, Strassburg CP, Manns MP. 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link. Genes Immun 2003 : 4 : 79 81.
10. Schwinzer R, Witte T, Hundrieser J et al. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C->G) in systemic sclerosis. Genes Immun 2003 : 4 : 168 9.
11. Consortium IH. A haplotype map of the human genome. Nature 2005 : 437 : 1299 320.
12. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 : 21 : 263 5.
13. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005 : 37 : 1217 23 Epub 23 Oct 2005 M, Beverley PC. Structural and functional analysis of the human CD45 gene (PTPRC) upstream region: evidence for a functional promoter within the first intron of the gene. Immunology 2001 : 102 : 180 9.
14. van Vliet SJ, Gringhuis SI, Geijtenbeek TB, van Kooyk Y. Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat Immunol 2006 : 7 : 1200 8.
15. Filip LC, Mundy NI. Rapid evolution by positive Darwinian selection in the extracellular domain of the abundant lymphocyte protein CD45 in primates. Mol Biol Evol 2004 : 21 : 1504 11.
16. Ballingall KT, Waibochi L, Holmes EC et al. The CD45 locus in cattle: allelic polymorphism and evidence for exceptional positive natural selection. Immunogenetics 2001 : 52 : 276 83.
17. Mustelin T, Vang T, Bottini N. Protein tyrosine phosphatases and the immune response. Nat Rev Immunol 2005 : 5 : 43 57.
18. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004 : 74 : 106 20.
19. Majeti R, Xu Z, Parslow TG et al. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 2000 : 103 : 1059 70.
20. Peisong G, Mao XQ, Enomoto T et al. An asthma-associated genetic variant of STAT6 predicts low burden of ascaris worm infestation. Genes Immun 2004 : 5 : 58 62.
21. Hellier S, Frodsham AJ, Hennig BJ et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 2003 : 38 : 1468 76.
22. Dawes R, Hennig B, Irving W et al. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection. J Med Genet 2006 : 43 : 678 84.
23. Jurinke C, van den Boom D, Cantor CR, Koster H. Automated genotyping using the DNA MassArray technology. Methods Mol Biol 2002 : 187 : 179 92.